These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 10850461

  • 1. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
    Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E, Kakolyris S, Georgoulias V, Gatter KC, Harris AL.
    Cancer Res; 2000 Jun 01; 60(11):3088-95. PubMed ID: 10850461
    [Abstract] [Full Text] [Related]

  • 2. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A, Sivridis E, Athanassou N, Zois E, Thorpe PE, Brekken RA, Gatter KC, Harris AL, Koukourakis IM, Koukourakis MI.
    J Pathol; 2001 May 01; 194(1):101-8. PubMed ID: 11329148
    [Abstract] [Full Text] [Related]

  • 3. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G, Zhao M, Xu M, Yang Y, Wang M, Yang C.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb 01; 25(2):89-93. PubMed ID: 11953105
    [Abstract] [Full Text] [Related]

  • 4. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C, Brambilla E.
    J Pathol; 1999 Aug 01; 188(4):369-77. PubMed ID: 10440746
    [Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, Harris AL.
    Br J Cancer; 2000 Apr 01; 82(8):1427-32. PubMed ID: 10780522
    [Abstract] [Full Text] [Related]

  • 6. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL.
    Br J Cancer; 2001 Sep 14; 85(6):881-90. PubMed ID: 11556841
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC.
    Clin Cancer Res; 1998 Dec 14; 4(12):3017-24. PubMed ID: 9865915
    [Abstract] [Full Text] [Related]

  • 8. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
    Giatromanolaki A, Sivridis E, Brekken R, Thorpe PE, Anastasiadis P, Gatter KC, Harris AL, Koukourakis MI, Tumour and Angiogenesis Research Group.
    Cancer; 2001 Nov 15; 92(10):2569-77. PubMed ID: 11745191
    [Abstract] [Full Text] [Related]

  • 9. [Vascular endothelial growth factor in non-small cell lung carcinoma expression and its significance].
    Yang G, Zhang L, Xie Y.
    Zhonghua Yi Xue Za Zhi; 1999 Feb 15; 79(2):104-5. PubMed ID: 11601013
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
    Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, Pairolero P, Trastek V, Jett J, Caporaso NE, Liotta LA, Harris CC.
    Clin Cancer Res; 2000 Dec 15; 6(12):4739-44. PubMed ID: 11156228
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas.
    Takahama M, Tsutsumi M, Tsujiuchi T, Nezu K, Kushibe K, Taniguchi S, Kotake Y, Konishi Y.
    Clin Cancer Res; 1999 Sep 15; 5(9):2506-10. PubMed ID: 10499626
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI, Tumor and Angiogenesis Research Group.
    Cancer; 2002 Sep 01; 95(5):1055-63. PubMed ID: 12209691
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.
    Aikawa H, Takahashi H, Fujimura S, Sato M, Endo C, Sakurada A, Kondo T, Tanita T, Matsumura Y, Ono S, Saito Y, Sagawa M.
    Anticancer Res; 1999 Sep 01; 19(5B):4305-9. PubMed ID: 10628391
    [Abstract] [Full Text] [Related]

  • 16. Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.
    Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Cox G, Thorpe PE, Gatter KC, Harris AL.
    Clin Cancer Res; 2000 May 01; 6(5):1917-21. PubMed ID: 10815916
    [Abstract] [Full Text] [Related]

  • 17. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma.
    Volm M, Koomägi R, Mattern J.
    Anticancer Res; 1996 May 01; 16(1):213-7. PubMed ID: 8615611
    [Abstract] [Full Text] [Related]

  • 18. Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Thorpe PE, Brekken RA, Konstantinos S, Fountzilas G, Gatter KC, Harris AL.
    Clin Exp Metastasis; 2000 May 01; 18(4):313-9. PubMed ID: 11448062
    [Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
    Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL, Gatter KC.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2485-92. PubMed ID: 9815651
    [Abstract] [Full Text] [Related]

  • 20. Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
    Kakolyris S, Giatromanolaki A, Koukourakis M, Leigh IM, Georgoulias V, Kanavaros P, Sivridis E, Gatter KC, Harris AL.
    Cancer Res; 1999 Nov 01; 59(21):5602-7. PubMed ID: 10554041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.